Resources

Selected
  • Mpox
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
56 results found
2024 ∙ Taha, A. M. Mahmoud, A. M. Abouelmagd, K. Saed, S. A. A. Khalefa, B. B. Shah, S. Satapathy, P. Shamim, M. A. Sah, S. Serhan, H. A. Donovan, S. Sah, R. Barboza, J. J.
Effectiveness of a single dose of JYNNEOS vaccine in real world: A systematic review and meta-analysis
All age groups Mpox Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Liu, H. Wang, W. Zhang, Y. Wang, F. Duan, J. Huang, T. Huang, X. Zhang, T.
Global perspectives on smallpox vaccine against monkeypox: a comprehensive meta-analysis and systematic review of effectiveness, protection, safety and cross-immunogenicity
All age groups Mpox Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Indiastari, D. Fajar, J. K. Tamara, F. Runesi, O. Hakim, L. N. Chotimah, K. Rahmani, A. Saputro, T. D. Afrilla, D. Firmansyah, E. Dau, D. Dzhyvak, V.
Global prevalence and determinants associated with the acceptance of monkeypox vaccination
All age groups Mpox Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Leon-Figueroa, D. A. Barboza, J. J. Siddiq, A. Sah, R. Valladares-Garrido, M. J. Rodriguez-Morales, A. J.
Knowledge and attitude towards mpox: Systematic review and meta-analysis
All age groups Mpox Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Eslami, A. Alimoghadam, S. Khoshravesh, S. Shirani, M. Alimoghadam, R. Alavi Darazam, I.
Mpox vaccination and treatment: a systematic review
All age groups Mpox Administration Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Mektebi, A. Elsaid, M. Yadav, T. Abdallh, F. Assker, M. Siddiq, A. Sayad, R. Saifi, M. Farahat, R. A.
Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis
Healthcare workers Mpox Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Mason, L. M. K. Betancur, E. Riera-Montes, M. Lienert, F. Scheele, S.
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings
All age groups Mpox Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Berry, M. T. Khan, S. R. Schlub, T. E. Notaras, A. Kunasekaran, M. Grulich, A. E. MacIntyre, C. R. Davenport, M. P. Khoury, D. S.
Predicting vaccine effectiveness for mpox
All age groups Mpox Modeling
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Leon-Figueroa, D. A. Barboza, J. J. Valladares-Garrido, M. J. Sah, R. Rodriguez-Morales, A. J.
Prevalence of intentions to receive monkeypox vaccine. A systematic review and meta-analysis
All age groups Mpox Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Pang, Y. Cao, D. Zhu, X. Long, Q. Tian, F. Long, X. Li, Y.
Safety and Efficacy of the Modified Vaccinia Ankara-Bavaria Nordic Vaccine Against Mpox in the Real World: Systematic Review and Meta-Analysis
All age groups Mpox Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...